Axcellant is excited to announce our participation at the European Association of Nuclear Medicine (EANM) Congress in Hamburg from October 19-23, 2024. We invite you to visit us and explore how our innovative CRO services in clinical trials and nuclear medicine can support your research and development efforts.
Our team will be available throughout the event to discuss cutting-edge solutions in medical imaging and radiopharmaceutical development. Whether you’re interested in exploring partnership opportunities, developing nuclear medicine procedures or learning about our latest projects, we look forward to connecting with you.
See you in Hamburg!
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant